These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28062571)

  • 1. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease.
    Flanagan ME; Marshall DA; Shofer JB; Montine KS; Nelson PT; Montine TJ; Keene CD
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):39-43. PubMed ID: 28062571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice.
    Bharadwaj R; Cimino PJ; Flanagan ME; Latimer CS; Gonzalez-Cuyar LF; Juric-Sekhar G; Montine TJ; Marshall DA; Keene CD
    Histopathology; 2018 Feb; 72(3):433-440. PubMed ID: 28815699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What every neuropathologist needs to know: condensed protocol work-up for clinical dementia syndromes.
    Multz RA; Spencer C; Matos A; Ajroud K; Zamudio C; Bigio E; Mao Q; Medeiros RA; Ahrendsen JT; Castellani RJ; Flanagan ME
    J Neuropathol Exp Neurol; 2023 Jan; 82(2):103-109. PubMed ID: 36458947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
    Hyman BT; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Carrillo MC; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Thies B; Trojanowski JQ; Vinters HV; Montine TJ
    Alzheimers Dement; 2012 Jan; 8(1):1-13. PubMed ID: 22265587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Montine TJ; Monsell SE; Beach TG; Bigio EH; Bu Y; Cairns NJ; Frosch M; Henriksen J; Kofler J; Kukull WA; Lee EB; Nelson PT; Schantz AM; Schneider JA; Sonnen JA; Trojanowski JQ; Vinters HV; Zhou XH; Hyman BT
    Alzheimers Dement; 2016 Feb; 12(2):164-169. PubMed ID: 26327235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
    Beach TG; Monsell SE; Phillips LE; Kukull W
    J Neuropathol Exp Neurol; 2012 Apr; 71(4):266-73. PubMed ID: 22437338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia in the Forensic Setting: Diagnoses Obtained Using a Condensed Protocol at the Office of Chief Medical Examiner, New York City.
    Priemer DS; Folkerth RD
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):724-730. PubMed ID: 34388235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
    Montine TJ; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Trojanowski JQ; Vinters HV; Hyman BT; ;
    Acta Neuropathol; 2012 Jan; 123(1):1-11. PubMed ID: 22101365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease-related plaques in nondemented subjects.
    Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
    Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.
    Alexopoulos P; Roesler J; Thierjung N; Werle L; Buck D; Yakushev I; Gleixner L; Kagerbauer S; Ortner M; Grimmer T; Kübler H; Martin J; Laskaris N; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):587-97. PubMed ID: 26253588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies.
    Latimer CS; Keene CD; Flanagan ME; Hemmy LS; Lim KO; White LR; Montine KS; Montine TJ
    J Neuropathol Exp Neurol; 2017 Jun; 76(6):458-466. PubMed ID: 28499012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a condensed protocol to assess limbic-predominant age-related TDP-43 encephalopathy neuropathologic change.
    Maioli H; Mittenzwei R; Shofer JB; Scherpelz KP; Marshall D; Nolan AL; Nelson PT; Keene CD; Latimer CS
    J Neuropathol Exp Neurol; 2023 Jun; 82(7):611-619. PubMed ID: 37195467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.
    Ringman JM; Monsell S; Ng DW; Zhou Y; Nguyen A; Coppola G; Van Berlo V; Mendez MF; Tung S; Weintraub S; Mesulam MM; Bigio EH; Gitelman DR; Fisher-Hubbard AO; Albin RL; Vinters HV
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):284-90. PubMed ID: 26888304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Preclinical" AD revisited: neuropathology of cognitively normal older adults.
    Schmitt FA; Davis DG; Wekstein DR; Smith CD; Ashford JW; Markesbery WR
    Neurology; 2000 Aug; 55(3):370-6. PubMed ID: 10932270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do NIA-AA criteria distinguish Alzheimer's disease from frontotemporal dementia?
    Harris JM; Thompson JC; Gall C; Richardson AM; Neary D; du Plessis D; Pal P; Mann DM; Snowden JS; Jones M
    Alzheimers Dement; 2015 Feb; 11(2):207-15. PubMed ID: 25022535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease.
    Geddes JW; Tekirian TL; Soultanian NS; Ashford JW; Davis DG; Markesbery WR
    Neurobiol Aging; 1997; 18(4 Suppl):S99-105. PubMed ID: 9330997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.
    Jellinger KA
    Neurodegener Dis; 2010; 7(1-3):112-5. PubMed ID: 20173339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
    Attems J; Jellinger KA
    Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.
    Leverenz JB; Agustin CM; Tsuang D; Peskind ER; Edland SD; Nochlin D; DiGiacomo L; Bowen JD; McCormick WC; Teri L; Raskind MA; Kukull WA; Larson EB
    Arch Neurol; 2002 Jul; 59(7):1099-106. PubMed ID: 12117357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.
    Brenowitz WD; Nelson PT; Besser LM; Heller KB; Kukull WA
    Neurobiol Aging; 2015 Oct; 36(10):2702-8. PubMed ID: 26239176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.